Not yet recruitingPhase 2NCT07432490
A Phase II Study With Exploratory Outcomes of Fucose Supplementation in GLUT1 Deficiency Syndrome
Studying Classic glucose transporter type 1 deficiency syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Oregon Health and Science University
- Principal Investigator
- Rodrigo T. Starosta, MD, PhD, ODOregon Health and Science University
- Intervention
- L-fucose(drug)
- Enrollment
- 16 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2026 – 2027
Study locations (1)
- Oregon Health and Science University, Portland, Oregon, United States
Collaborators
Glut1 Deficiency Foundation
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT07432490 on ClinicalTrials.govOther trials for Classic glucose transporter type 1 deficiency syndrome
Additional recruiting or active studies for the same condition.
See all trials for Classic glucose transporter type 1 deficiency syndrome →